
Private equity investment in the Asia-Pacific region is increasingly flowing into advanced manufacturing and healthcare, as global uncertainties push investors towards businesses with more predictable cash flow, according to Bain & Co research.
The move away from the previously dominant technology, media and telecommunications sector “has been a gradual move, driven by the external environment and uncertainties”, said Elsa Sit, practice vice-president in the Asia-Pacific private equity team with the global management consulting firm. “We see a shift towards … sectors that can offer more stable returns and more predictable cash flows.”
The shift came as fundraising for Asia-Pacific-focused private equity funds weakened, marking a fourth straight year of decline in 2025, according to Bain’s report published on Tuesday, based in part on a poll of 121 Asia-Pacific private equity general partners in November.
Advertisement
Total capital raised by these funds fell to US$58 billion last year, a 12-year low, with the amount raised down 37 per cent from a year earlier.
“Limited partners are more selective in picking the funds they want to bet on,” Sit said. “They are clearly backing those general partners who have a stronger track record, the ability to offer portfolio value-add, and to manage and exit the portfolio successfully and secure attractive returns for their limited partners.”
Advertisement
The technology, media and telecoms sector remained the largest destination for Asia-Pacific private equity in 2025, but its share of deal value fell to a 10-year low – about 25 per cent, the report revealed.

Don't Miss:
-
Iran says peace deal with US ‘never been closer’, as Pakistan says final text agreed on
-
Elon Musk becomes world’s first trillionaire after SpaceX IPO
-
Britain’s David Hockney, a giant of contemporary art, dies aged 88
-
2 infants in Hong Kong confirmed severely infected with Covid-19 just days apart
-
Huawei is considering deploying Ascend AI chips in Latin America, cloud chief says

Thai Princess Kept Alive Artificially For More Than Three Years Dies
Indie Film Causes Consternation Among Overseas Chinese
Lowering doses of cancer drugs could slash global health spending by $30B, new research shows